« Back
Home /
Human IgG1 Isotype Control (IB1) LALA [ICH2254LALA]

Human IgG1 Isotype Control (IB1) LALA [ICH2254LALA]

Manufacturer	IchorBio
Category	Reagents & Chemicals Biochemicals Controls
Type	Antibody Monoclonal
Specific against	Human
Clone	IB1
Isotype	IgG1
Applications	FC, FA
Amount	10mg
Host	CHO cells
Item no.	ICH2254LALA-10mg
eClass 6.1	32160702
eClass 9.0	42030590
Available
Manufacturers Product Category	Low Endotoxin, isotype control
Target Information	IgG1
Isotype Information	Human IgG1
Purification method	This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background	Recombinant IgG1 human antibody
Concentration	≥ 5.0 mg/ml
Formulation	This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Endotoxin	<1.0 EU/mg as determined by the LAL method
Aggregation	Aggregation level ≤ 5%
Storage	This antibody is stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Application Notes	Each investigator should determine their own optimal working dilution for specific applications.
Use	Products are for research use only. Not for use in diagnostic or therapeutic procedures.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10mg

available

Delivery expected until 6/6/2024